Investigating how estrogen affects Alzheimer's disease in women
Estrogen, Astrocyte Reactivity, and Sex Differences in Alzheimer's Disease
This study is looking at how lower estrogen levels might make women more likely to experience memory problems and other symptoms of Alzheimer's disease, using mice to find ways to help improve brain health for women facing this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10662993 on NIH RePORTER |
What this research studies
This research explores the role of estrogen deficiency in the increased vulnerability of women to Alzheimer's disease (AD). It focuses on understanding how lower estrogen levels in the brain may contribute to memory deficits and other symptoms associated with AD. The study utilizes mouse models to examine the effects of aromatase, an enzyme that converts androgens to estrogens, on brain function and astrocyte reactivity. By analyzing changes in brain cells and memory performance, the research aims to uncover potential therapeutic targets for improving outcomes in women with AD.
Who could benefit from this research
Good fit: Ideal candidates for this research are postmenopausal women who are experiencing cognitive decline or have been diagnosed with Alzheimer's disease.
Not a fit: Patients who are male or those who do not have Alzheimer's disease may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that specifically address the unique vulnerabilities of women to Alzheimer's disease.
How similar studies have performed: Previous research has indicated that hormonal factors play a significant role in Alzheimer's disease, suggesting that this approach may yield valuable insights.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Zhao, Hong — Northwestern University at Chicago
- Study coordinator: Zhao, Hong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.